Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1995 Jun;86(6):555–561. doi: 10.1111/j.1349-7006.1995.tb02434.x

Intracranial Germ Cell Tumors: Detection of p53 Gene Mutations by Single‐strand Conformation Polymorphism Analysis

Xuelian Feng 1,2, Shujing Zhang 1, Tomio Ichikawa 1, Hisashi Koga 1,3, Kazuo Washiyama 1, Teiichi Motoyama 4, Toshiro Kumanishi 1,✉
PMCID: PMC5920873  PMID: 7622420

Abstract

Using polymerase chain reaction‐single‐strand conformation polymorphism (PCR‐SSCP) analysis, p53 gene mutation was examined in 12 intracranial germ cell tumors (5 yolk sac carcinomas and 7 germinomas), many of which were derived from young patients in the first to the second decade. A total of 10 mutations were detected in 4 of the 12 cases and, in 3 of them, the mutations were multiple or tandem. Among the 10 mutations, 7 were missense, 1 was splicing and 2 were silent. The 7 missense mutations were located at previously proposed hot spot codons or in their vicinity or, when outside the hot spots, at a codon encoding an amino acid conserved in most vertebrates. These findings suggested that all 7 missense mutations may actually give rise to functional alteration of the p53 protein. The splicing mutation was considered to be a germ‐line mutation, though its biological effect was equivocal, since the neoplastic tissue contained an additional mutation. The pattern of the mutations was predominancy of G:C‐A:T transition with frequent involvement of the CpG site. These mutations were more frequently detected in yolk sac carcinomas (60%; 3/5 cases) than in germinomas (14%; 1/7 cases), suggesting that the contribution of the p53 mutation to carcinogenesis differed with the histological type of the intracranial germ cell tumor.

Keywords: Germ cell tumor, Brain tumor, Teratoma, p53 gene mutation, Tumor suppressor gene

Full Text

The Full Text of this article is available as a PDF (433.2 KB).

REFERENCES

  • 1. ) Russell , D. S. and Rubinstein , L. J. “ Pathology of the Tumours of the Nervous System ,” 5th Ed. , pp. 665 – 690 ( 1989. ). Edward Arnold; , London . [Google Scholar]
  • 2. ) Hollstein , M. , Sidransky , D. , Vogelstein , B. and Harris , C. C.p53 mutations in human cancers . Science , 253 , 49 – 53 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Baker , S. J. , Fearon , E. R. , Nigro , J. M. , Hamilton , S. R. , Preisinger , A. C. , Jessup , J. M. , van Tuinen , P. , Ledbetter , D. H. , Barker , D. F. , Nakamura , Y. , White , R. and Vogelstein , B.Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas . Science , 244 , 217 – 221 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Eliyahu , D. , Michalovitz , D. , Eliyahu , S. , Pinhasi‐Kimhi , O. and Oren , M.Wild‐type p53 can inhibit oncogene‐mediated focus formation . Proc. Natl. Acad. Sci. USA , 86 , 8763 – 8767 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Finlay , C. A. , Hinds , P. W. and Levine , A. J.The p53 proto‐oncogene can act as a suppressor of transformation . Cell , 57 , 1083 – 1093 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Isobe , M. , Emanuel , B. S. , Givol , D. , Oren , M. and Croce , C. M.Localization of gene for human p53 tumour antigen to band 17p13 . Nature , 320 , 84 – 85 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Lamb , P. and Crawford , L.Characterization of the human p53 gene . Mol. Cell. Biol. , 6 , 1379 – 1385 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Miller , C. , Mohandas , T. , Wolf , D. , Prokocimer , M. , Rotter , V. and Koeffler , H. P.Human p53 gene localized to short arm of chromosome 17 . Nature , 319 , 783 – 784 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Soussi , T. , de Fromentel , C. C. and May , P.Structural aspects of the p53 protein in relation to gene evolution . Oncogene , 5 , 945 – 952 ( 1990. ). [PubMed] [Google Scholar]
  • 10. ) Chung , R. , Whaley , J. , Kley , N. , Anderson , K. , Louis , D. , Menon , A. , Hettlich , C. , Freiman , R. , Hedley‐Whyte , E. T. , Martuza , R. , Jenkins , R. , Yandell , D. and Seizinger , B. R.TP53 gene mutations and 17p deletions in human astrocytomas . Genes Chromosomes Cancer , 3 , 323 – 331 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Frankel , R. H. , Bayona , W. , Koslow , M. and Newcomb , E. W.p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency . Cancer Res. , 52 , 1427 – 1433 ( 1992. ). [PubMed] [Google Scholar]
  • 12. ) Fults , D. , Brockmeyer , D. , Tullous , M. W. , Pedone , C. A. and Cawthon , R. M.p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression . Cancer Res. , 52 , 674 – 679 ( 1992. ). [PubMed] [Google Scholar]
  • 13. ) Koga , H. , Zhang , S. , Kumanishi , T. , Washiyama , K. , Ichikawa , T. , Tanaka , R. and Mukawa , J.Analysis of p53 gene mutations in low‐ and high‐grade astrocytomas by polymerase chain reaction‐assisted single‐strand conformation polymorphism and immunohistochemistry . Acta Neuropathol. , 87 , 225 – 232 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Mashiyama , S. , Murakami , Y. , Yoshimoto , T. , Sekiya , T. and Hayashi , K.Detection of p53 gene mutations in human brain tumors by single‐strand conformation polymorphism analysis of polymerase chain reaction products . Oncogene , 6 , 1313 – 1318 ( 1991. ). [PubMed] [Google Scholar]
  • 15. ) Nigro , J. M. , Baker , S. J. , Preisinger , A. C. , Jessup , J. M. , Hostetter , R. , Cleary , K. , Bigner , S. H. , Davidson , N. , Baylin , S. , Devilee , P. , Glover , T. , Collins , F. S. , Weston , A. , Modali , R. , Harris , C. C. and Vogelstein , B.Mutations in the p53 gene occur in diverse human tumour types . Nature , 342 , 705 – 708 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Saxena , A. , Clark , W. C. , Robertson , J. T. , Ikejiri , B. , Oldfield , E. H. and Ali , I. U.Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas . Cancer Res. , 52 , 6716 – 6721 ( 1992. ). [PubMed] [Google Scholar]
  • 17. ) Sidransky , D. , Mikkelsen , T. , Schwechheimer , K. , Rosenblum , M. L. , Cavanee , W. and Vogelstein , B.Clonal expansion of p53 mutant cells is associated with brain tumour progression . Nature , 355 , 846 – 847 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 18. ) von Deimling , A. , Eibl , R. H. , Ohgaki , H. , Louis , D. N. , von Ammon , K. , Petersen , I. , Kleihues , P. , Chung , R. Y. , Wiestler , O. D. and Seizinger , B. R.p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma . Cancer Res. , 52 , 2987 – 2990 ( 1992. ). [PubMed] [Google Scholar]
  • 19. ) Zhang , S. , Feng , X. , Koga , H. , Ichikawa , T. , Abe , S. and Kumanishi , T.p53 gene mutations in pontine gliomas of juvenile onset . Biochem. Biophys. Res. Commun. , 196 , 851 – 857 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Badiali , M. , Iolascon , A. , Loda , M. , Scheithauer , B. W. , Basso , G. , Trentini , G. P. and Giangaspero , F.p53 gene mutations in medulloblastoma—immunohistochemistry, gel shift analysis, and sequencing . Diagn. Mol. Pathol. , 2 , 23 – 28 ( 1993. ). [PubMed] [Google Scholar]
  • 21. ) Ohgaki , H. , Eibl , R. H. , Wiestler , O. D. , Yasargil , M. G. , Newcomb , E. W. and Kleihues , P.p53 mutations in non‐astrocytic human brain tumors . Cancer Res. , 51 , 6202 – 6205 ( 1991. ). [PubMed] [Google Scholar]
  • 22. ) Yoshimoto , K. , Iwahana , H. , Fukuda , A. , Sano , T. , Saito , S. and Itakura , M.Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction‐single strand conformation polymorphism . Cancer Res. , 52 , 5061 – 5064 ( 1992. ). [PubMed] [Google Scholar]
  • 23. ) Goelz , S. E. , Hamilton , S. R. and Vogelstein , B.Purification of DNA from formaldehyde fixed and paraffin embedded human tissue . Biochem. Biophys. Res. Commun. , 130 , 118 – 126 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Hsu , I. C. , Metcalf , R. A. , Sun , T. , Welsh , J. A. , Wang , N. J. and Harris , C. C.Mutational hotspot in the p53 gene in human hepatocellular carcinomas . Nature , 350 , 427 – 428 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Orita , M. , Suzuki , Y. , Sekiya , T. and Hayashi , K.Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction . Genomics , 5 , 874 – 879 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Sanger , F. , Nicklen , S. and Coulson , A. R.DNA sequencing with chain‐terminating inhibitors . Proc. Natl. Acad. Sci. USA , 74 , 5463 – 5467 ( 1977. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Wagata , T. , Shibagaki , I. , Imamura , M. , Shimada , Y. , Toguchida , J. , Yandell , D. W. , Ikenaga , M. , Tobe , T. and Ishizaki , K.Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas . Cancer Res. , 53 , 846 – 850 ( 1993. ). [PubMed] [Google Scholar]
  • 28. ) Frebourg , T. , Kassel , J. , Lam , K. T. , Gryka , M. A. , Barbier , N. , Andersen , T. I. , Borresen , A.‐L. and Friend , S. H.Germ‐line mutations of p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein . Proc. Natl. Acad. Sci. USA , 89 , 6413 – 6417 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. ) Heimdal , K. , Lothe , R. A. , Lystad , S. , Holm , R. , Fossa , S. D. and Borresen , A.‐L.No germline TP53 mutations detected in familial and bilateral testicular cancer . Genes Chromosomes Cancer , 6 , 92 – 97 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Kihana , T. , Tsuda , H. , Teshima , S. , Okada , S. , Matsuura , S. and Hirohashi , S.High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy . Jpn. J. Cancer Res. , 83 , 978 – 984 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. ) Peng , H.‐Q. , Hogg , D. , Malkin , D. , Bailey , D. , Gallie , B. L. , Bulbul , M. , Jewett , M. , Buchanan , J. and Goss , P. E.Mutations of the p53 gene do not occur in testis cancer . Cancer Res. , 53 , 3574 – 3578 ( 1993. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES